{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:39:28Z","timestamp":1791819568495,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jinf.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T18:49:26Z","timestamp":1529434166000},"page":"291-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease"],"prefix":"10.1016","volume":"77","author":[{"given":"E","family":"Moran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Baharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dedicoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bhomra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OS","family":"Thien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jinf.2018.06.003_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.jinf.2018.06.003_bib0002","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/rheumatology\/keu172","article-title":"Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies","volume":"53","author":"Souto","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jinf.2018.06.003_bib0003","unstructured":"Medicines and Healthcare Products Regulatory Agency,\u00a0Tumour necrosis factor alpha inhibitors drug safety update, April 2014, available at https:\/\/www.gov.uk\/drug-safety-update\/tumour-necrosis-factor-alpha-inhibitors."},{"issue":"12","key":"10.1016\/j.jinf.2018.06.003_bib0004","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5588\/ijtld.15.0081","article-title":"Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis","volume":"19","author":"Al-Efraij","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"10.1016\/j.jinf.2018.06.003_bib0005","first-page":"989","article-title":"Risk of tuberculosis in dialysis patients: a population-based study","volume":"2","author":"Chia","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.jinf.2018.06.003_bib0006","doi-asserted-by":"crossref","first-page":"e69556","DOI":"10.1371\/journal.pone.0069556","article-title":"Increased risk of active tuberculosis following acute kidney injury: a nationwide, population-based study","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS ONE (Public Library of Science)"},{"issue":"1","key":"10.1016\/j.jinf.2018.06.003_bib0007","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0950268813000551","article-title":"Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease","volume":"142","author":"Hu","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2018.06.003_bib0008","doi-asserted-by":"crossref","unstructured":"British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee, Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, et al. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. BMJ Publishing Group Ltd and British Thoracic Society; 2010. 65 pp. 55770.","DOI":"10.1136\/thx.2009.133173"},{"issue":"6","key":"10.1016\/j.jinf.2018.06.003_bib0009","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2018.06.003_bib0010","unstructured":"Tuberculosis in England: 2017 report [Internet]. 1st ed. gov.uk. London; [cited 2017 Oct 16]. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/654152\/TB_Annual_Report_2017.pdf."},{"key":"10.1016\/j.jinf.2018.06.003_bib0011","doi-asserted-by":"crossref","first-page":"43478","DOI":"10.1038\/srep43478","article-title":"The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays","volume":"7","author":"Tanner","year":"2017","journal-title":"Sci Rep"},{"issue":"37","key":"10.1016\/j.jinf.2018.06.003_bib0012","first-page":"873","article-title":"Tuberculosis transmission in a renal dialysis center\u2013Nevada, 2003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.jinf.2018.06.003_bib0013","first-page":"28","article-title":"A retrospective review of the two-step tuberculin skin test in dialysis patients","volume":"3","author":"Foster","year":"2016","journal-title":"Can J Kidney Health Dis"},{"issue":"11","key":"10.1016\/j.jinf.2018.06.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188631","article-title":"Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: a latent-class analysis","volume":"12","author":"Doan","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2018.06.003_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.jinf.2018.06.003_bib0016","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1469-0691.2009.02949.x","article-title":"Validity of interferon-\u03b3-release assays for the diagnosis of latent tuberculosis in haemodialysis patients","volume":"16","author":"Chung","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.jinf.2018.06.003_bib0017","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/TP.0000000000000451","article-title":"The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis","volume":"99","author":"Ferguson","year":"2015","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.jinf.2018.06.003_bib0018","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/CVI.00166-12","article-title":"Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment","volume":"19","author":"Oni","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2018.06.003_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12879-015-1117-3","article-title":"Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2018.06.003_bib0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jinf.2013.07.029","article-title":"Dynamic changes in positive interferon-gamma release assay in a dialysis population: An observational cohort study","volume":"67","author":"Shu","year":"2013","journal-title":"J Infect"},{"issue":"22","key":"10.1016\/j.jinf.2018.06.003_bib0021","doi-asserted-by":"crossref","first-page":"e3813","DOI":"10.1097\/MD.0000000000003813","article-title":"Risk of tuberculosis among patients on dialysis: the predictive value of serial interferon-gamma release assay","volume":"95","author":"Shu","year":"2016","journal-title":"Medicine (Baltimore)"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:26:23Z","timestamp":1759008383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318301798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0163445318301798"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.06.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}